 { path { fill: %23EEEFE9 } })
Finger prick blood test trial 'could revolutionise' Alzheimer's diagnosis, say experts
Ground News • • general
Key Points:
- The Bio-Hermes-002 international clinical trial is exploring whether a simple finger-prick blood test can revolutionize Alzheimer's disease diagnosis.
- The study involves 1,000 participants aged 60 and above from the UK, US, and Canada, aiming to identify specific blood biomarkers linked to Alzheimer's.
- This blood test could potentially replace invasive diagnostic methods like specialized brain scans and lumbar punctures.
- If successful, the test could be easily administered in GP surgeries, making Alzheimer’s diagnosis more accessible and less burdensome.
%3Amax_bytes(150000)%3Astrip_icc()%2FFoods-You-Should-Buy-Every-Week-if-Youre-Taking-Ozempic-7bc85d310f074e0bacd33383c26fa41c.jpg?format=webp&w=1280)